Press Release New Jersey
Press Release
Reproductive Freedom for All Condemns Louisiana Attorney General’s Baseless Attack on Mifepristone
For Immediate Release: Thursday, October 9, 2025
Contact: m[email protected]
Reproductive Freedom for All Condemns Louisiana Attorney General’s Baseless Attack on Mifepristone
Washington, DC – On Monday, Louisiana Attorney General Liz Murrill filed a lawsuit against the U.S. Food and Drug Administration (FDA), asking them to reverse a 2023 policy change that allows doctors to prescribe mifepristone via telehealth.
This case is just the latest state attack on medication abortion—anti-abortion states and groups continued a federal lawsuit in a Texas district court last year challenging the FDA in its decades-old approval of mifepristone, which was just transferred to a district court in Missouri. Texas Attorney General Ken Paxton has also been targeting out-of-state providers who have dispensed mifepristone via telehealth with legal action.
Reproductive Freedom for All President and CEO Mini Timmaraju released the following statement:
“This is nothing more than another attempt to advance an anti-abortion agenda. Much like other baseless lawsuits attempting to restrict access to mifepristone, this case lacks standing, has zero merit, and should be dismissed immediately. Mifepristone is safe and effective, and it has been used by more than five million people in the United States since its FDA approval over 25 years ago.”
###
For over 55 years, Reproductive Freedom for All (formerly NARAL Pro-Choice America) has fought to protect and advance reproductive freedom at the federal and state levels—including access to abortion care, birth control, pregnancy and post-partum care, and paid family leave—for everybody. Reproductive Freedom for All is powered by its more than 4 million members from every state and congressional district in the country, representing the 8 in 10 Americans who support legal abortion.